Theodoros V. Giannouchos

Dr. Theodoros V. Giannouchos


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Toxicology Reports
Verified
Journal Article
Open access
Konstantinos FarsalinosKonstantinos Farsalinos
Konstantinos Farsalinos
Konstantinos PoulasKonstantinos Poulas
Konstantinos Poulas
Dimitrios KouretasDimitrios Kouretas
Dimitrios Kouretas
Apostolos VantarakisApostolos Vantarakis
Apostolos Vantarakis
MLMichalis Leotsinidis
Michalis Leotsinidis
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
• The COVID-19 pandemic has challenged the healthcare capacity of many countries. • Strict, horizontal lockdowns have adverse social, economic and health effects that have not been fully considered. • Primary and community care have multiple roles in COVID-19 pandemic mitigation. • Greece is a case example of a country which neglected primary and community care, and in November 2020 implemented a second horizontal lockdown. • Primary and community care, represents the only realistic strategy for successful COVID-19 pandemic mitigation in the long-term.

2 May 2019 in Journal of Evaluation in Clinical Practice
Verified
Journal Article
Closed access
PDF file
TGTheodoros V. Giannouchos
Theodoros V. Giannouchos
HKHye‐Chung Kum
Hye‐Chung Kum
MFMargaret Foster
Margaret Foster
RORobert L. Ohsfeldt
Robert L. Ohsfeldt

1 February 2021 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
TGTheodoros V. Giannouchos
Theodoros V. Giannouchos
JBJoseph Biskupiak
Joseph Biskupiak
MMMichael J. Moss
Michael J. Moss
DBDiana Brixner
Diana Brixner
EAElena Andreyeva
Elena Andreyeva
BUBenjamin Ukert
Benjamin Ukert

14 June 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
TGTheodoros V. Giannouchos
Theodoros V. Giannouchos
BUBenjamin Ukert
Benjamin Ukert
CAChristina Andrews
Christina Andrews
Emergency departments (EDs) are a vital component of the US health care system, with more than 140 million visits in 2018 incurring a total cost of approximately $75 billion.1 Emergency department visits are expected to increase even further in the years ahead, by a projected 12% by 2030.2,3 Although EDs treat patients with acute and unexpected health care conditions, they often serve as a safety net for individuals who are unable to access other health care settings. The use of EDs for nonemergent and preventable medical conditions has been a long-standing challenge in the US health care system. Every year, it is estimated that one-third of all ED visits occur for care that is treatable in primary care settings and preventable.4-6 At an average cost that is many times higher compared with treatment provided at a physician’s office or an urgent care center, some of these visits suggest inefficient allocation of resources and present a cost-saving opportunity.7

5 March 2020 in Journal of Evaluation in Clinical Practice
Verified
Journal Article
Closed access
PDF file
TGTheodoros V. Giannouchos
Theodoros V. Giannouchos
DWDavid J. Washburn
David J. Washburn
JGJodie C. Gary
Jodie C. Gary
MFMargaret J. Foster
Margaret J. Foster

13 July 2019 in Clinical Drug Investigation
Verified
Journal Article
Closed access
TGTheodoros V. Giannouchos
Theodoros V. Giannouchos
DMDimos-Dimitrios Mitsikostas
Dimos-Dimitrios Mitsikostas
RORobert L. Ohsfeldt
Robert L. Ohsfeldt
AVAthanassios Vozikis
Athanassios Vozikis
PKParaskevi Koufopoulou
Paraskevi Koufopoulou